An oral deuterated pentoxifylline analog demonstrates a favorable safety and improves clinical outcomes in adults with ...

This 55-year-old female is in good general health. She is not a diabetic, and is a smoker. Current medications include Dilantin ®, glucosamine, and vitamin E. In the past she has used New Zealand ...

Dr. Keith Roach writes a medical question-and-answer column weekdays. Dear Dr. Roach: My girlfriend has necrobiosis lipoidica. She suffers from this on her shins, as did her mother. She is not ...

In a press release Dr. David Young, CEO of Processa said "We plan to begin our clinical studies in 2018 and to accelerate the development of PCS499 in order to provide clinical benefit to [necrobiosis ...

HANOVER, March 17, 2021 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) ("Processa" or the "Company"), a clinical stage company developing drugs for patients who have unmet medical ...

HANOVER, MD, Aug. 04, 2022 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (NASDAQ: PCSA), (“Processa” or the “Company”), a clinical-stage biopharmaceutical company developing products to improve ...

An 87-year-old man presented with a 3-month history of localized asymptomatic erythema on the flexor aspect of the lower right leg (Figure 1). The lesion was surrounded by a red ridge with a clear ...

The global ulcerated necrosis lipoidica management market sales is expected to reach a remarkable valuation of US$ 4.4 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) ...

A 22-year-old woman with type 1 diabetes presented with a 10-year history of a yellow–red, telangiectatic plaque 7 cm in diameter with central atrophy on her left forearm (Figure 1). The edges of the ...

Necrobiosis lipoidica diabeticorum (NLD) is a rare skin condition in which lesions normally develop on the lower part of the legs Other body parts can be affected, though. NLD occurs due to collagen ...